ID

26206

Description

A sample trial to demonstrate the end-to-end application of the CDISC Standards and transformations from ADL

Mots-clés

  1. 11/10/2017 11/10/2017 - Philipp Bruland
Détendeur de droits

Unknown

Téléchargé le

11 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC-ND 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Sample Study

Adverse Events

Common
Description

Common

Alias
TEST
Common ItemGroup Alias
Site number
Description

Site Number as assigned by CRO

Type de données

integer

Alias
SDTM
SITEID
Subject ID
Description

Subject ID

Type de données

text

Alias
SDTM
USUBJID
Visit Date
Description

Visit Date

Type de données

date

Visit Start Time
Description

Visit Time

Type de données

time

Adverse events
Description

Adverse events

Has the subject experienced any adverse events
Description

Adverse Event Experienced

Type de données

integer

Adverse events
Description

Adverse events

Event No.
Description

Adverse Event Number

Type de données

integer

Adverse event
Description

Adverse Event Term

Type de données

text

Start Date
Description

Adverse Event Start Date

Type de données

date

Is the adverse event still continuing
Description

Adverse Event Continues

Type de données

integer

Stop Date
Description

Adverse Event Stop Date

Type de données

date

Duration of the adverse event
Description

AE duration

Type de données

durationDatetime

Was event serious
Description

Adverse Event Serious

Type de données

integer

Severity
Description

Adverse Event Severity

Type de données

integer

Action taken with study drug
Description

Adverse Event Action Taken

Type de données

integer

Subject outcome
Description

Adverse Event Subject Outcome

Type de données

integer

Similar models

Adverse Events

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Common
Common ItemGroup Alias (TEST)
Site Number
Item
Site number
integer
SITEID (SDTM)
Subject ID
Item
Subject ID
text
USUBJID (SDTM)
Visit Date
Item
Visit Date
date
Visit Time
Item
Visit Start Time
time
Item Group
Adverse events
Item
Has the subject experienced any adverse events
integer
Code List
Has the subject experienced any adverse events
CL Item
No (0)
CL Item
Yes (1)
Item Group
Adverse events
Adverse Event Number
Item
Event No.
integer
Adverse Event Term
Item
Adverse event
text
Adverse Event Start Date
Item
Start Date
date
Item
Is the adverse event still continuing
integer
Code List
Is the adverse event still continuing
CL Item
No (0)
CL Item
Yes (1)
Adverse Event Stop Date
Item
Stop Date
date
AE duration
Item
Duration of the adverse event
durationDatetime
Item
Was event serious
integer
Code List
Was event serious
CL Item
No (0)
CL Item
Yes (1)
Item
Severity
integer
Code List
Severity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Is there a reasonable possibility that the AE may have been caused by the study drug
integer
Code List
Is there a reasonable possibility that the AE may have been caused by the study drug
CL Item
No (0)
CL Item
Yes (1)
Item
Action taken with study drug
integer
Code List
Action taken with study drug
CL Item
None (1)
CL Item
Study drug regimen changed (2)
CL Item
Temporarily stopped study drug (3)
CL Item
Study drug discontinued (4)
Item
Subject outcome
integer
Code List
Subject outcome
CL Item
Subject remains in study (1)
CL Item
Withdrawn from study (2)
CL Item
Lost to follow-up (3)
CL Item
Death (4)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial